Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 16 studies with search of: | "Neopharm" [Exact] |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
|
||||
2 | Active, not recruiting |
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
|
||||
3 | Not yet recruiting |
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
|
||||
4 | Active, not recruiting |
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
|
||||
5 | Active, not recruiting |
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer
|
||||
6 | Completed |
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies
|
||||
7 | Active, not recruiting |
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
|
||||
8 | Completed |
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
|
||||
9 | Active, not recruiting |
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
|
||||
10 | Active, not recruiting |
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer
|
||||
11 | Terminated |
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
|
||||
12 | Active, not recruiting |
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
|
||||
13 | Active, not recruiting |
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
|
||||
14 | Terminated |
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
|
||||
15 | Active, not recruiting |
Pre-Operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
|
||||
16 | Completed |
Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer
|